Stay updated on SKI-G-801 Dose Study in AML Clinical Trial

Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the page's metadata. This reflects a small, non-substantive update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-04-30T17:54:59.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:24.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The record was updated in 2024 with a new last update date and QC status; no changes to the core study design, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-03-25T21:03:48.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T15:53:29.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:25:33.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The two screenshots reflect the same study record without changes to core content such as study title, conditions, interventions, eligibility criteria, or outcome measures.
    Difference
    0.1%
    Check dated 2026-03-04T12:46:41.000Z thumbnail image

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.